ライフサイエンスコーパス: sneezing

1 ial aerosol-generating events (eg, coughing, sneezing).

2 y reduced rhinorrhea, nasal obstruction, and sneezing.

3 were nasal stuffiness, nasal discharge, and sneezing.

4 infected ferrets during normal breathing and sneezing.

5 mptoms were nasal stuffiness, discharge, and sneezing.

6 nificant amount of S. aureus into the air by sneezing.

7 sessions with and without histamine-induced sneezing.

8 ng protective reflexes that include apnea or sneezing.

9 n of fever, muscle ache, scratchy throat, or sneezing.

10 plets (aerosols) via exhaling, coughing, and sneezing.

11 n B (NMB) peptide is essential for signaling sneezing.

12 roduced via breathing, talking, coughing, or sneezing.

13 CI 5.02-8.39), hair loss (3.99, 3.63-4.39), sneezing (2.77, 1.40-5.50), ejaculation difficulty (2.63

14 is, including nasal itching, rhinorrhea, and sneezing, although most agents are not very effective in

15 ol groups, except for a greater incidence of sneezing and application site reaction (99% mild or mode

16 Sneezing and coughing are primary symptoms of many respi

17 It is generally assumed that sneezing and coughing involve common sensory receptors a

18 Relative to sneezing and coughing, non-symptomatic aerosol-producing

19 rotransmission/modulation mechanisms between sneezing and coughing, offering neuronal drug targets fo

20 ing an unforeseen sensory difference between sneezing and coughing.

21 presence of at least two symptoms: 'repeated sneezing and itchy nose', 'blocked nose for more than on

22 e, despite physical forces such as coughing, sneezing and mucociliary clearance.

23 rted improvements in smell and reductions in sneezing and nasal blockade.

24 The third year was better with sneezing and nasal discharge than the 2nd year, and the

25 peated BK challenges led to tachyphylaxis of sneezing and of neurally mediated serous glandular secre

26 presence of >/=1 rhinitis symptom (repeated sneezing and/or itchy nose, blocked nose for >1 h, or ru

27 eceptively well; he or she will have coryza, sneezing, and a mild cough.

28 Coughing, sneezing, and even talking emit respiratory droplets whi

29 ssociated with symptoms of nasal congestion, sneezing, and itching of the eyes, nose, and throat.

30 congestion, rhinorrhea, postnasal drainage, sneezing, and itching of the eyes, nose, and throat.

31 ere weight loss, ocular and nasal discharge, sneezing, and lethargy.

32 nerve evokes protective reflexes, including sneezing, apnea, and local neurogenic inflammation of th

33 ncreased cough, sore throat, runny nose, and sneezing are associated with the emergence of the Omicro

34 e provides specific relief of rhinorrhea and sneezing associated with common colds.

35 tion potentials in cVRG neurons and leads to sneezing behavior.

36 ically ~0.6-500 um in diameter (by coughing, sneezing, breathing, and talking).

37 Sneezing caused a 4.7-fold increase in the airborne disp

38 s respiratory depression, nasal obstruction, sneezing, cough, and pain.

39 e throat, nasal discharge, nasal congestion, sneezing, cough, scratchy throat, hoarseness, muscle ach

40 treatment period; most were mild, nonocular (sneezing, cough, throat irritation, and instillation sit

41 ease in pressure in the upper airways during sneezing, coughing, or vomiting, which very rarely leads

42 sociated with barotrauma to the orbit due to sneezing, coughing, or vomiting.

43 s after being struck in his right eye by his sneezing Dachshund dog.

44 induced clinical symptoms such as coughing, sneezing, decreased activity, fever, and labored breathi

45 d point was defined after excluding the item sneezing due to its low ability to discriminate severity

46 stsynaptic to nasal sensory neurons mediates sneezing in this region.

47 sues involved such symptoms include itching, sneezing, irritation, vasodilation, and reflex secretion

48 sons through exhaling, talking, coughing and sneezing is a major driver of SARS-CoV-2 transmission, w

49 Sneezing is a vital respiratory reflex frequently associ

50 ported blocked nose, 48% rhinorrhea, and 46% sneezing/itchy nose.

51 ction occurs but can include red itchy eyes, sneezing, nasal congestion, rhinorrhea, coughing, bronch

52 reatment reduced the severity of rhinorrhea, sneezing, nasal obstruction, sore throat, cough, and hea

53 t of colored dye that approximated a patient sneezing on a dimensionally accurate cardboard slit lamp

54 03), ipratropium was associated with reduced sneezing on study days 2 (20% difference; P = 0.03) and

55 The effects of sneezing on the airborne dispersal of S. aureus and othe

56 rus exposure did not change the frequency of sneezing or airborne dispersal.

57 t two nasal symptoms: rhinorrhoea, blockage, sneezing or itching.

58 questionnaire: 484 (48.3%) had at least one sneezing, or a runny or blocked nose episodes without co

59 pharyngeal samples (shedding), coughing, and sneezing (P < .05).

60 (P = .004), 83% for daily summation operator sneezing (P = .001), 75% for daily summation operator wa

61 y delineates a peptidergic pathway mediating sneezing, providing molecular insights into the sneezing

62 ezing, providing molecular insights into the sneezing reflex arc.

63 or deficiency in NMB receptor abolished the sneezing reflex.

64 population (MrgprC11(+)MrgprA3(-)) mediates sneezing responses to a multitude of nasal irritants, al

65 nitis was defined as one or more episodes of sneezing, runny and/or blocked nose >2 weeks duration.

66 Pollen-AR was defined as sneezing, runny, itchy or blocked nose; and itchy or wat

67 d the spread of S. aureus by 3.8-fold during sneezing sessions (P < .001).

68 r, and >/=2 of runny nose, nasal congestion, sneezing, sore throat, cough, swollen or tender neck gla

69 the absence of symptoms such as coughing or sneezing, the importance of speech-generated aerosol in

70 hniques, we mimic the effect of coughing and sneezing, thereby testing the force stability of SARS-Co

71 s positive accompanied with nasal discharge, sneezing, throat discomfort, swelling of the uvula.

72 tostatin [SST(+)]) mediates coughing but not sneezing, unraveling an unforeseen sensory difference be

73 x responses, including expiration, coughing, sneezing, vomiting, postural control, production of spee

74 blocked nose, runny nose, nasal itching, and sneezing was used to evaluate symptoms.

75 erized by typical symptoms of nasal itching, sneezing, watery discharge and congestion.

76 inical signs, including fever, coughing, and sneezing, were present in both groups.

77 tionally emphasized the role of coughing and sneezing, which are dramatic expiratory events that yiel

78 re involved in sinonasal ciliary response to sneezing, which is blunted in patients with upper-airway

79 RA) model for impulse emissions, coughing or sneezing, with aerosolized synthetic DNA tracer concentr

80 uses itching, nasal congestion, and repeated sneezing, with profound effects on quality of life, work

81 having nasal obstruction, secretion, and/or sneezing without having the common cold.